Decreased expression of IL-33 in immune thrombocytopenia.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Immunopharmacology

• Publication date

  2015-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.intimp.2015.06.035PMID 26164496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders.

  2015cited by this paper
• Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma

  2014cited by this paper
• IL-33 promotes airway remodeling and is a marker of asthma disease severity

  2014cited by this paper
• The Alarmin IL-33 Promotes Regulatory T Cell Function in the Intestine

  2014cited by this paper
• IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy.

  2014cited by this paper
• Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP)

  2014cited by this paper
• Imbalanced expression of human Tim-1 and Tim-3 in peripheral blood mononuclear cells from immune thrombocytopenia patients.

  2014cited by this paper
• The Role of the Serum IL-33/sST2 Axis and Inflammatory Cytokines in Chronic Obstructive Pulmonary Disease

  2014cited by this paper
• Virus-like particles presenting interleukin-33 molecules

  2014cited by this paper
• Interleukin (IL)-33: new therapeutic target for atopic diseases.

  2014cited by this paper
• Emerging role of interleukin‐33 in autoimmune diseases

  2014cited by this paper
• T cell immune abnormalities in immune thrombocytopenia

  2014cited by this paper
• Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma

  2014cited by this paper
• Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.

  2014cited by this paper
• Expression of IL-33 and its epigenetic regulation in multiple sclerosis

  2014cited by this paper
• IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling.

  2014cited by this paper
• Advances in immunopathogenesis of adult immune thrombocytopenia

  2013cited by this paper
• Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.

  2013cited by this paper
• Complement regulation of T-cell alloimmunity.

  2013cited by this paper
• The interleukin-1 family: back to the future.

  2013cited by this paper
• The interleukin-1 receptor family.

  2013cited by this paper
• CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia.

  2013cited by this paper
• Evidence for a regulatory loop between IFN‐γ and IL‐33 in skin inflammation

  2013cited by this paper
• Serum IL-33 levels and skin mRNA expression in Behçet's disease.

  2013cited by this paper
• The IL-33/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB/c Mice Infected with Leishmania donovani

  2013cited by this paper
• Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients.

  2012cited by this paper
• Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells*

  2012cited by this paper
• Regulation of Th1/Th2 polarization by tissue inhibitor of metalloproteinase-3 via modulating dendritic cells.

  2012cited by this paper
• IL-33/ST2 axis in inflammation and immunopathology

  2012cited by this paper
• T-cell biology in aging, with a focus on lung disease.

  2012cited by this paper
• Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity

  2012cited by this paper
• In vitro recovery of Th1/Th2 balance in PBMCs from patients with immune thrombocytopenia through the actions of IL-18BPa/Fc.

  2011cited by this paper
• Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia

  2011cited by this paper
• IL-33 Expands Suppressive CD11b+ Gr-1int and Regulatory T Cells, including ST2L+ Foxp3+ Cells, and Mediates Regulatory T Cell-Dependent Promotion of Cardiac Allograft Survival

  2011cited by this paper
• The biological paths of IL‐1 family members IL‐18 and IL‐33

  2011cited by this paper
• ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma

  2011cited by this paper
• Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus.

  2010cited by this paper
• International consensus report on the investigation and management of primary immune thrombocytopenia.

  2010cited by this paper
• Interleukin 18 and interleukin 18 binding protein in patients with idiopathic thrombocytopenic purpura

  2009cited by this paper
• IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

  2008cited by this paper
• Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies

  2008cited by this paper
• IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

  2007cited by this paper
• Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura.

  2007cited by this paper
• IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

  2005cited by this paper
• Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response.

  2004cited by this paper
• High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura

  2003cited by this paper

• The link between immune thrombocytopenia and the cytokine profile: a bridge to new therapeutical targets

  2023cites this paper
• Interleukin-33 Reinvigorates Antiviral Function of Viral-Specific CD8+ T Cells in Chronic Hepatitis B Virus Infection

  2021cites this paper
• Interleukin (IL)-1 family cytokines could differentiate primary immune thrombocytopenia from systemic lupus erythematosus-associated thrombocytopenia

  2021cites this paper
• Interleukin (IL)-1 family cytokine in primary immune thrombocytopenia: a comparison with systemic lupus erythematosus-associated thrombocytopenia

  2020cites this paper
• Interaction analysis of miR-1275/IGF2BP1/IGF2BP3 with the susceptibility to hepatocellular carcinoma.

  2020cites this paper
• A functional polymorphism in the promoter region of IL-33 is associated with the reduced risk of colorectal cancer.

  2019cites this paper
• Genetic variants in IL-33/ST2 pathway with the susceptibility to hepatocellular carcinoma in a Chinese population.

  2019cites this paper
• STUDY OF INTERLEUKIN-33 IN IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDREN

  2019cites this paper
• The role of the IL-33/ST2 axis in autoimmune disorders: Friend or foe?

  2019cites this paper
• Dynamic changes of soluble ST2 levels predicted fatality and were involved in coagulopathy in dengue fever in the elderly

  2019cites this paper
• Association between functional polymorphisms in IL‐33/ST2 pathway and risk of osteosarcoma

  2018cites this paper
• Preliminary study about the mechanism of IL-33 acting on neutrophil apoptosis in rates with acinetobacter baumannii pneumonia

  2016cites this paper
• [Distribution characteristics of rs1891385A/C and rs10975519C/T polymorphisms of interleukin-33 gene in Guangxi population].

  2016cites this paper